Extremity Medical announced FDA 510(k) clearance for Axis Charcot, a comprehensive axial fixation system. First cases are scheduled for this month.
This product and the recently-released BioFuse next-gen live-cell bone graft are two of the company’s 16 products available globally to treat distal lower and upper extremities. Other 2017 launches include KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.
Sources: Extremity Medical, LLC; ORTHOWORLD Inc.
Extremity Medical announced FDA 510(k) clearance for Axis Charcot, a comprehensive axial fixation system. First cases are scheduled for this month.
This product and the recently-released BioFuse next-gen live-cell bone graft are two of the company's 16...
Extremity Medical announced FDA 510(k) clearance for Axis Charcot, a comprehensive axial fixation system. First cases are scheduled for this month.
This product and the recently-released BioFuse next-gen live-cell bone graft are two of the company’s 16 products available globally to treat distal lower and upper extremities. Other 2017 launches include KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.
Sources: Extremity Medical, LLC; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
